Testing a new medication to help preserve pancreas function in early-stage type 1 diabetes

This research trial is investigating whether semaglutide—a medication that helps control blood sugar—can help protect your pancreas's insulin-producing cells in the earliest stages of type 1 diabetes. Researchers believe this medication might delay or reduce the need for insulin injections by improving how your body handles blood sugar. The study will involve taking the medication once during a special glucose tolerance test to see how it affects your body's response.

Type 1 diabetes progresses through stages, and in the very early stages, there's a critical window when the pancreas still produces some insulin. Current treatments haven't fully addressed the metabolic problems that happen during this window. This trial aims to explore whether this medication can help preserve remaining pancreas function and improve overall metabolic health during these early stages.